These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4660855)

  • 21. [Clinical evaluation of rifampicin in advanced pulmonary tuberculosis resistant to conventional antituberculosis drugs. Combination therapy with rifampicin and pyrazinamide].
    Yamamoto M; Isoe K; Izumi S; Fuse M
    Kekkaku; 1971 Jul; 46(7):259-64. PubMed ID: 5114108
    [No Abstract]   [Full Text] [Related]  

  • 22. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on results of rifampicin treatment after surgical failure].
    Kekkaku; 1972 Aug; 47(8):261-8. PubMed ID: 4660854
    [No Abstract]   [Full Text] [Related]  

  • 24. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis.
    Gyselen A; Verbist L; Cosemans J; Lacquet LM; Prignot J; Simon-Pouthier F; Debrabandere R; Devriendt J
    Acta Tuberc Pneumol Belg; 1969; 60(3):563-76. PubMed ID: 4906105
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of rifampicin in venous perfusion in a group of patients with pulmonary tuberculosis].
    Bettini L; Fossati C
    Clin Ter; 1976 Nov; 79(3):263-72. PubMed ID: 1017171
    [No Abstract]   [Full Text] [Related]  

  • 26. Trial of rifampicin in the treatment of pulmonary tuberculosis. Results at 12 months.
    Sriyabhaya N; Jarumilin A
    J Med Assoc Thai; 1972 Apr; 55(4):235-7. PubMed ID: 5022496
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A controlled comparison of daily and intermittent administration of rifampicin in retreatment of pulmonary tuberculosis].
    Yamamoto K; Aizawa H; Sasaoka M; Kawamori Y; Kakuno J
    Kekkaku; 1972 Dec; 47(12):467-73. PubMed ID: 4652425
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of Soviet-made rifampicin in pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Kolesnikova ZhIa; Petrash OV
    Vrach Delo; 1978 Oct; (10):52-6. PubMed ID: 716359
    [No Abstract]   [Full Text] [Related]  

  • 30. [Note on a clinical trial of rifampicin in the treatment of pulmonary tuberculosis].
    Robustelli Pisani F
    G Ital Mal Torace; 1969; ():Suppl 2:85+. PubMed ID: 4982436
    [No Abstract]   [Full Text] [Related]  

  • 31. [Possibilities and limitations of long-term treatment with rifampicin infusion in tubercular disease].
    Rosetti L; Serra A; Arba GV
    G Ital Chemioter; 1982; 29(2):125-32. PubMed ID: 7186465
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis].
    Petrova GN; Sedunova EA; Korotaeva TA
    Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397
    [No Abstract]   [Full Text] [Related]  

  • 33. [A five year follow-up study of antituberculosis chemotherapy with and without rifampicin (author's transl)].
    Matsumiya T; Yoshida F; Inoue M; Yoshimura M; Ogawa T; Yoshida R; Ishii A
    Kekkaku; 1980 Feb; 55(2):43-51. PubMed ID: 7373965
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative study on the pharmacokinetics of rifampicin between the old and middle-aged tuberculosis patients].
    Weng FH
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Oct; 13(5):292-4, 319. PubMed ID: 2085859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 36. [Team-controlled study the effectiveness of chemotherapy with outpatients with fibrous-cavitary tuberculosis].
    Margulis NIu; Korotaev GA; Golubeva VN; Iusman ZI; Roslik SM
    Probl Tuberk; 1984 Jun; (6):6-11. PubMed ID: 6382251
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rifampicin; its value and its limitations in tuberculosis, chronic or of severe onset, with or without associated ethambutol].
    Tricoire J; Marécaux L
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):226-41. PubMed ID: 5385585
    [No Abstract]   [Full Text] [Related]  

  • 38. [The clinical use of rifampicin in tuberculosis].
    Giuliano V
    G Ital Mal Torace; 1969; ():Suppl 2:50-9. PubMed ID: 5357139
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of pulmonary tuberculosis with rifampicin].
    Brocard H; Akoun G; Depierre A; Muon N; Tobe FM
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):211-25. PubMed ID: 5385584
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical and radiological results of rifampicin therapy in chronic pulmonary tuberculosis].
    Merenda P
    G Ital Mal Torace; 1969; ():Suppl 2:105-6. PubMed ID: 5357132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.